×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: amyloid-cascade-hypothesis
mechanism
2,586 words
KG: amyloid
Contents
amyloid-cascade-hypothesis
⚙
Mechanism Info
Name
amyloid
Key Genes/Proteins
APOE
,
PARP1
,
TDP43
,
SQSTM1
,
CASP3
,
CLU
Related Diseases
Alzheimer's Disease
,
cognitive deficits
,
Alzheimer's disease
Linked Hypotheses
13 hypotheses
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49
Complement C1q Mimetic Decoy Therapy
Score: 0.48
Age-Dependent Complement C4b Upregulation Drives Synaptic Vu
Score: 0.47
Glycosaminoglycan Template Disruption Approach
Score: 0.46
HDAC3-Selective Inhibition for Clock Reset
Score: 0.46
Complement C1q Subtype Switching
Score: 0.44
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor
Score: 0.42
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.40
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
APOE-Dependent Autophagy Restoration
Score: 0.61
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (20)
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.46
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.46
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.46
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.46
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.46
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.46
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.46
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.46
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.46
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.46
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Mouse Cdk5, p35, and p39 mutations in neuronal migration
validation · proposed · Score: 0.80
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.46
Vascular Contribution to Alzheimer's Disease — Beyond Amyloi
validation · proposed · Score: 0.46
Show 15 more
See Also (5)
ACE Gene
gene · KG edge: activates
ABI3 Gene
gene · KG edge: activates
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates
A2M Gene
gene · KG edge: interacts_with
ABCA7 (Redirect)
redirect · KG edge: activates
Knowledge Graph (12 edges)
amyloid
causes
cognitive deficits
amyloid
associated_with
Alzheimer's disease
amyloid
activates
oxidative stress
amyloid
drives
Alzheimer's Disease
CD33
loss_affects
amyloid
CX3CR1
co_discussed
amyloid
PARP1
co_discussed
amyloid
TDP43
co_discussed
amyloid
SQSTM1
co_discussed
amyloid
CASP3
co_discussed
amyloid